AI in Healthcare Industry 2022 - Players Include 3M, Abbott and Acupath Laboratories Among Others

News provided by

Feb 10, 2022, 15:45 ET

DUBLIN, Feb. 10, 2022 /PRNewswire/ -- The "Artificial Intelligence in Healthcare: Intellectual Property Landscape" report has been added to ResearchAndMarkets.com's offering.

This report features an extensive study of the historical and current collection of granted patents, patent applications and affiliated documents associated with the upcoming suite of intuitive software and automation enabling solutions, which are designed for use within the healthcare industry. The information in this report has been presented across two deliverables, namely an Excel sheet, featuring an interactive dashboard, and a PowerPoint presentation, summarizing the ongoing activity in this domain, and key insights drawn from the available data.

The global healthcare sector has been overtly reluctant to embrace technology. This may partially be due to the failure of early digitization efforts, which were fraught with challenges and turned out to be more of a liability rather than a path forward. In fact, according to a study, clinicians ended up spending more than twice as much time on administrative work (49%), such as updating electronic medical records, than on seeing patients (27%). The delivery of modern healthcare services is, therefore, still in many ways obsolete, relying on analog systems and manual execution on simple, repetitive operations.

This situation is challenging for both healthcare providers (resulting in long and arduous work hours, causing medical staff to burn themselves out) and consumers (which is reflected in hurried, inappropriate diagnosis, lack of proper care and delays in treatment administration). Further, experts have predicted that if things don't change significantly, there is likely to be a severe shortage of healthcare workers in the mid to long term. Similar inefficiencies exist in the pharmaceutical development segment as well, with over USD 800 million being spent on drug discovery alone; a typical product development cycle in this domain lasts close to a decade and costs USD 2.5 billion, on average. However, advances in automation and intuitive software have made it possible for stakeholders to markedly improve operational efficiencies and cut-down on both operational and administrative expenses.

Today, self-learning algorithms are being used to develop AI that can not only help automate various simple and complex tasks but can also assist clinicians in making critical diagnosis / treatment related decisions. It is estimated that over 33% of the tasks that are performed manually by clinicians can be automated, and there are artificially intelligent solutions that are capable of carrying out specialized functions, such as patient triage, without human supervision.

Over the last couple of decades, computer scientists and medical researchers have successfully demonstrated the applications of AI in several diverse aspects of healthcare delivery, including (but not limited to) surgery, drug discovery and hospital / patient data management. The use of self-improving algorithms also guarantees cost savings; experts estimate that savings worth over USD 150 billion can be achieved by 2026, through the adoption of AI-enabled technologies, in the US alone. As a result, a lot of capital and effort are being invested by innovators across the world in this burgeoning field of research. This report attempts to identify key trends that describe the pace and focus of innovation related to healthcare focused AI technologies and solutions.

The report features the following details:

Overall Intellectual Property Landscape

An in-depth review of the various patents and affiliated IP documents that have been published related to technologies and methods associated with the healthcare-related applications of AI, featuring key insights on historical and recent trends.

Popular / Relevant Prior Art Search Expressions

An examination of IP literature, identifying key words and phrases that are used to describe innovations involving the use of AI and other intuitive algorithms for healthcare-focused applications, including information on historical usage in IP filings, key affiliated terms (which can be used to further identify similar innovations), and other related trends.

Patent Valuation Analysis

A competitive benchmarking and valuation analysis of the IP documents published in this field of innovation, taking into account important parameters, such as type of IP document, year of application, time to expiry, number of citations and jurisdiction (factoring in regional GDP).

Patentability and Freedom to Operate

A systematic approach to identifying relevant areas of innovation by analyzing published IP documents, defining the uniqueness patented / patent pending innovations, understanding the scope of patentability in this domain, and pinpointing jurisdictions where new and / or modified claims may be filed without infringing on existing IP.

Analysis of Patent Applications

A detailed summary of the patent applications that were filed across different jurisdictions and their relative value in the IP ecosystem. The analysis segregates the intellectual capital in terms of area of innovation and intended applications, thereby, offering the means to understand key areas of research and identify innovation-specific IP filing trends.

Analysis of Granted Patents

An elaborate summary of the granted patents across different jurisdictions and their relative value in the IP ecosystem. The analysis uses a slightly more specific segregation criteria, based on type of product / solution and intended applications; this offers the means to identify unique innovations that presently have marketing exclusivity and explore future opportunities to enter into promising product markets, once their patents expire.

Pockets of Innovation and White Spaces

An insightful analysis of the various CPC symbols mentioned in the published IP literature used and their affiliated families, in order to identify historical and existing pockets of innovation (based on the functional area / industry described by the elaborate and systematic system of classifying IP); the analysis also features a discussion on the prevalent white spaces (based on CPC symbols) in this area of research.

Claims Analysis

One of the key objectives of the report was to analyze and summarize key inferences from the independent claims mentioned in the granted, active patents in the entire dataset. Using a systematic segregation approach, we have analyzed trends associated with [A] the preamble, [B] type of patent (technology patent or method patent), [C] type of claim (open ended claim or closed ended claim) and [D] key elements of a claim (individual aspects of an innovation that are covered in a singular claim).

Key Topics Covered:

Excel Deliverable

1. Data Collection Guide

2. Summary Dashboard
A. Overall Patent Landscape
B. Key Prior Art Search Expressions
C. Overall Valuation Analysis
D. Patentability and Freedom to Operate
E. Key Trends related to Patent Applications
F. Key Trends related to Granted Patents
G. Impact on COVID-19 Pandemic on IP Filing / Grant

3. Overall Intellectual Property Landscape Dataset

4. Prior Art Search Expressions

5. Patent Applications Dataset

6. Granted Patents Dataset

7. Claims Analysis

8. Patentability and Freedom to Operate Dataset

9. Impact of COVID-19 Pandemic Dataset

10. Appendix I: Pivot Tables

11. Appendix II: Country / Geography Codes

PowerPoint Deliverable

1. Context

2. Project Approach

3. Project Objectives

Section I
4.Executive Summary

Section II
5. Healthcare Applications of Artificial Intelligence and Affiliated Solutions
5.1. Overview
5.2. Popular Technologies and Solutions
5.2.1. Watson (IBM)
5.2.2. DeepMind (DeepMind Technologies, a Subsidiary of Alphabet)
5.2.3. Other Intuitive Software / Technologies
5.3. Concluding Remarks

6. Overall Intellectual Property Landscape

7. Analysis of Prior Art Search Expressions

8. Intellectual Property Valuation Analysis

Section III
9. Patentability and Freedom to Operate

Section IV
10. Analysis of Patent Applications
10.1. Overview
10.2. Relative Valuation of Patent Applications
10.3. Analysis of Patent Applications
10.3.1. Analysis by Central and Peripheral IP Documents
10.3.2. Analysis by Legal Status
10.3.3. Analysis by Key Innovation Areas and Applications
10.4. Concluding Remarks

Section V
11. Analysis of Granted Patents
11.1. Overview
11.2. Relative Valuation of Granted Patents
11.3. Analysis of Granted Patents
11.3.1. Analysis by Central and Peripheral IP Documents
11.3.2. Analysis by Legal Status
11.3.3. Analysis by Key Innovation Areas and Applications
11.4. Key Applicants & Innovator Profiles
11.5. Claims Analysis
11.6. Concluding Remarks

12. Pockets of Innovation and White Spaces

Section VI
13. Impact of COVID-19 Pandemic

14. Conclusion and Future Outlook

15. Appendices

Companies Mentioned

20/20 GeneSystems
23andMe
360 Knee Systems
3D Smile
3M
3SI Security Systems
410Ai
7D Surgical
Aarhus University
Abbott
Abiomed
Abraxis Bioscience
Accenture
Access Radiology
Accessible Conseils
Acto
Acupath Laboratories
Advanced Medical Imaging Development
Advanced Mobile Payment
Advanced Neuromodulation Systems
Advanced Solutions Life Sciences
AdviNOW Medical
Advisory Board
AetharAI
Affymetrix
Agency for Science, Technology and Research
Agilent Technologies
Agility Capital
Agios Pharmaceuticals
Agricultural Information Institute (AII) of Chinese Academy of Agricultural Sciences
AI Fluidics
AI Technology
Aidot
Air Products
Ajinomoto
Akili Biosystems
Akili Interactive
Akitra
Aktana
AlayaCare
Alcaris Theranostics
Alegeus
Algotec
Alibaba Group
Align Technology
AlignCare
Alipay Information Technology
Alivia Capital
Allegheny-Singer Research Institute
Allen Institute
AllOne Health
Allscripts
Altair
AltheaDX
Altrics
Alverix
Alverix
Alyce Health
Ambry Genetics
Ameican TelePhysicians
American Board of Family Medicine
Americrop Investments
Amino
Ampel BioSolutions
Amrita Vishwa Vidyapeetham
Amuseneering
Ancestry
Answers
Apixio
Apogee Informatics
Apostle
Applera Corporation
Applied Brain Research
Applied Invention
Applied Investments
Applied Minds
Applied Proteomics
APT International Business Sciences
Aptar
ARC Devices
Archimedes
Architecture Technology Corporation
Argo
Arizona Board of Regents, Arizona State University
ArmadaGlobal
ArmadaHealth
Arterys
Artificial Learning Systems
Ascriptus
ASP Global
Aspen Neuroscience
Aspira Women's Health
Asthma Signals
Astrazeneca
Astrid Pharma
AT & T Intellectual Property
Athelas
ATONARP
Augmedix
AUM Cardiovascular
Aureon Laboratories
Australian Institute of Robotic Orthopaedics
Avago Technologies
Aventusoft
Aveva
Aviir
Azova
Babylon
Bagne-Miller Enterprises
Baidu USA
Baker Heart and Diabetes Institute
Banner Health
Banyan Biomarkers
BaseHealth
BASF Plant Science
Battelle Memorial Institute
Baxalta
Baxter International
Bayer
Bayer
Baylor College of Medicine
Bean Holdings
Bechtel
Beckman Coulter Diagnostics
Becton Dickinson
Beijing Boyuan Xingkang Science and Technology
Beijing Guhai Tianmu Biomedical Technology
Beijing Institute of Genomics
Beijing Medical Cloud Technology
Beijing Muyebang Technology
Beijing Qiji Biotechnologynology
Beijing Tianhe Wisdom Health
Beijing Tuberculosis And Thoracic Tumor Research Institute
Beijing University of Technology
Beijing Wanfang Data
Beijing Xbentury Network Technology
Beijing Xiangxin Biotechnology
Beijing Xiangxin Medical Technology
Beijing Yikang Medical Technology
Bellsouth Intellect
Benevis Informatics
BenevolentAI
Berg Health
Berkeley Lights
Berlin Institute for Health Research
Bespoke
Beta Bionics
Beyondspring Pharmaceuticals
Bhogar
Bio Imaging Korea
Bio Synergy Research Center
Bioanalytics Group
Bioanalytix
Bioarray Genetics
Biofield
Bioinfra
Bioinfra Life Science
Biokaizen
Biomar
Biome
Bionous
Biophysical Corporation
Bioretics
Bios Health
Biosensors International
Biosymetrics
Biotempus
Bio-Thera
Biotie Therapies
Biowulf Technologies
Bired Imaging
Blackthaorn Therapeutics
Bloom Technologies
Bluarc Capital
Bluarc Health
Blue Note Therapeutics
Bluestar Genomics
BOE Technology
Bomdic
Bosch
Bose Corporation
Boston Research Corporation
Boston Scientific Neuromodulation
Bostongene
Bracco Imaging
Brain Power Systems
Brain Trust Innovations
Brainbox Solutions
Brainchip Holdings
Brainehealth
Brainlab
Brainwide Solutions
Brigham and Women's Hospital
Brighterion
Britescan
Broad Institute
Broadcom
Buck Institute for Research on Aging
Business Expectations
Buzzpole
Caduceus Systems
Caldwell Intellectual Property Law
California Institute of Technology
Cambia Health Solutions
Cambridge Bio-Augmentation Systems
Cancer Commons
Cancer Prevention Pharmaceuticals
Cannabics Pharmaceuticals
Canon Medical Systems
Canon USA
Capital.com
Capitalbio Technology
Cardiocom
CardioDx
CareFusion
Careoregon
Carepartners Plus
Caris Life Sciences
Carlsmed
Carrot
Case Western Reserve University
Casio
Catalia Health
Catalight Foundation
Caterpillar
Catholic University of Korea
CC&I Research
Cedars-Sinai Medical Center
Celgene
Cellanyx
Cellcarta
Cell-El Therapeutics
Cellmic
Cellomics
Cellworks Life
Celmatix
Center for Eye Research, Australia
Center for Medical Interoperability
CentriHealth
Centurylink
Ceridian
Cerner
Cerner
Cerner
Cerora
Certara
CES
Chamberlin Edmonds & Associates
Champalimaud Foundation
Chan Zuckerberg Biohub
Chang Gung University
Changchun Meihe Science and Technology Development
Change Healthcare
Change Healthcare
Chase Therapeutics
Chen Technology
Children's Hospital and Medical Center
Children's Hospital of Fudan University
Children's Medical Center
Children's National Medical Center
China Institute for Radiation Protection
China Medical University
China Telecom
Chongqing University Cancer Hospital
Cigna
Cincinati Children's Hospital Medical Center
Cipher Gene
Cirtec Medical
Citi
Citrix
City University of Hong Kong
Cixi Institute of Biomedical Engineering
Clarify Health Solutions
Clarion
CLAS Healthcare
ClearAg
Cleave Therapeutics
Cleveland Clinic
Cleveland Heartlab
Clinical Genomics
Clinicalbox
Clover Health
Codexis Mayflower Holdings
Cofactor Genomics
Cogent Biosciences
Cogito
CognitiveScale
Cognoa
Cohero Health
Colibri Technologies
Collective Health
Colon Health Centers of America
Color
Colossio
Commonwealth Scientific and Industrial Research Organisation
Community Care of North Carolina
ComplexData
Compressus
Compressus
Computer Technology Associates
Conduent
Conduent
Conifer Health Solutions
Connance
Connectix Corporation
ConnSante Biotech
ConquerAb
CooperSurgical
CoreMedica Europe
Corista
Corista
Cornell University
Correlogic Systems
CortexXus
CorVista Health
COTA
Cotinga Pharmaceuticals
Council of Scientific and Industrial Research
Counsyl
Covera Health
Covidien
Coyne Scientific
Crescendo Bioscience
Critical Connection
Crowe
Crowley Davis Research
CSC Holdings
CSTS Health Care
CTRL-Labs
CURA4U
Curai Health
Curamatix Healthcare
Curelon
Curemark
CureMatch
Curneu MedTech Innovation
Cutaneous Information Technologies
Cyberdontics
Cyberkinetics Neurotechnology Systems
Cyrcadia
Cyrcadia
Cyrcadia
Cytognomix
Cytokinetics
D&P Biotech
Dacadoo
Daegu Gyeongbuk Institute of Science and Technology
Daiwa House
Dako
Dana-Farber Cancer Institute
Dartmouth College
Datagenno Interactive Research
DatCard
DayaMed
Decipher by Veracyte
DecisionQ
deCode Genetics
Deep Bio
Deep Genomics
Deep Longevity
Deep Smart Light
DeepCare
DeepIntent
DeepLife
DeepNoid
DeepWise
Definiens
Definiens
Delphinus Medical Technologies
Demala
Denka
DePuySynthes
Dexcom
Diagnoplex
Diagnoss
Dianon Systems
DIG Labs
DigiM Solution
Digital Infuzion
Digital Medical Experts
Dignity Health
Direct Supply
Disney Enterprises
DM Intelligence
DoAI
Doc.Ai
Dommar
Dr. Eyal Bressler
Drager
Draper
DrFirst
Drishti
DTN
Duke University
Dyax
Dynamic Imaging
DYSIS Medical
DZee Solutions
EBM Technologies
Ebonz
eCare21
EchelonDx
Ecosense
EDP Biotech
Eight Sleep
EIO Diagnostics
ELC Management
Electronics and Telecommunications Research Institute
Elekta
Elements of Genius
Ellipsis Health
Elucid
Elwha
Elwha
Embraer
EMC Holdings
EMED Technologies
Emfit
Emory University
Empire IP
eNano Health
Endpoint Health
Engauge
Entelos
Entelos Holding Corporation
Entelos Holding Corporation
Environmental Technologies Group
Envisagenics
EPFL
EQ Holdings
Equity
eSentire
eSight Eyeware
Essen BioScience
Essenlix Corporation
Estimo Healthcare
ETH Zurich
Ethicon
EuclidSR Partners
Europroteome AG
Evalytica
Evidera
Evogen
Exact Imaging
Exini
EXINI Diagnostics
Exosome Diagnostics
Experian Health
ExperTune
Express Scripts
Eyes, Japan
Facebook Technology
Facet
Family Inada
Fasotec
Federral State Autonomous Educational Institution of Higher Education
FEI Company
FICO
First Opinion
Flatiron Health
Fujitsu
Geisinger
GenePlus
General Electric
GeneType
Georgia Tech Research Institute
German Cancer Research Center
German Cancer Research Center
Global Foundries
Global Life Sciences Solutions USA
Grail
Grail
GX Life Technology
Harbin Institute of Technology
Harvard
Health Diagnostic Laboratory
Health Dialog
HealthTrio
Healthways
HeartFlow
Highland Innovations
Hitachi
Hologic
Human Longevity
Humana
IBM
IBM
Icahn School of Medicine, Mt. Sinai
Imsight Technology
Included Health
Inspirata
Interleukin Genetics
Intuit
Invention Science Fund Incubator
Invention Science Fund Incubator
IQVIA
J. Morita USA
Juno Therapeutics
Jurosense
Knowledge Vision (Chengdu)
Korea Advanced Institute of Science and Technology
KPN Ventures
Lifeline Biotechnologies
LifeQ
Live Networks
Mayo Clinic
Mckesson
Medis Medical Imaging
Medtronic
Memorial Sloan Kettering Cancer Center
Mentis Cura
Merge
Merit CRO
MicroMass
Microsoft
Moffitt Cancer Center
Nanjing Shihe Gene Biotechnology
NantOmics
NantWorks
National Center for Scientific Research, France
Natural Institute for Health and Medical Research
Navican
NEC
New York Genome Center
Northrop Grumman
Opko Diagnostics
Optimata
Paradromics
PatientsLikeMe
Peraton
Philip Morris International
Philips
Philips
Progenics Pharmaceuticals
Psomagen
Public Health Research Center
Pulse Biosciences
Quantum Leap Healthcare Collaborative
Reliance
Ricoh
Roche
Roche
Roche
Samsung Electronics
Samsung Life Public Welfare Foundation
Selvas AI
Seoul National University
Shanghai Center for Bioinformation Technology
Shanghai Internationa Trading
Shimadzu Corporation
Siemens
Siemens Healthineers
SmartMirror
Smith+Nephew
Smiths Detection
SomaLogic
Sony
Sun Yat-Sen University Cancer Center
Sunnybrook Research Institute
Surgical Theater
Sysmex
Tempus
Terumo
Tethys Bioscience
The Hartford
The National Center for Scientific Research (CNRS)
UniServices
University of Connecticut
University of Freiburg
University of Nebraska
University of New Mexico, Science & Technology Corporation
University of Texas
Wellvii
Wision AI
Zalicus
Zeiss

For more information about this report visit https://www.researchandmarkets.com/r/5o8xr4

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets